Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118232 · ClinicalTrials.gov registry record · Phase 4
Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization
A Phase 4 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 4
- Development phase
- 13,952
- Enrollment target
NCT03118232: Completed Phase 4 study, sponsored by University of California, Irvine.
NCT03118232 is a Phase 4 study that has completed, run by University of California, Irvine. The registered enrollment target is 13,952 participants, above the 517-participant average among 9,235 other Phase 4 trials with a reported enrollment target (2599% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03118232, a Phase 4 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13,952 participants
- Enrollment target
Study Summary
This is a cluster-randomized trial of nursing homes to assess whether decolonization with routine chlorhexidine bathing and periodic use of nasal antiseptics can reduce hospitalizations associated with infections, antibiotic utilization, and multi-drug resistant organism (MDRO) prevalence. The comparator arm will be routine bathing care.
Primary Outcome
Probability that a transfer to a hospital is due to an infection
Interventions
- DRUG Chlorhexidine gluconate (CHG)
- DRUG Iodophor (10% povidone-iodine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,952 participants |
| Start Date | 2017-04-03 |
| Est. Completion | 2023-10-10 |
| Phase | Phase 4 |
What the finished NCT03118232 record still lists
NCT03118232 is an interventional study that assigns participants to a tested intervention. Its 13,952 participants enrollment target places it among the larger protocols in the corpus, above the 517-participant average among 9,235 other Phase 4 trials with a reported enrollment target (2599% higher).
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine gluconate (CHG) is the first listed.
NCT03118232 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03118232 about?
NCT03118232 is a clinical study titled "Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization". This is a cluster-randomized trial of nursing homes to assess whether decolonization with routine chlorhexidine bathing and periodic use of nasal antiseptics can reduce hospitalizations associated with infections, antibiotic utilization, and multi-drug resistant organism (MDRO) prevalence. The compa...
What is the current status of trial NCT03118232?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13,952 participants. The study started on 2017-04-03. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT03118232?
The interventions under investigation include: Chlorhexidine gluconate (CHG) (DRUG), Iodophor (10% povidone-iodine) (DRUG).
Who is sponsoring clinical trial NCT03118232?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03118232's enrollment target sits among peer trials
13,952 7th of 2000 higher than 1,994 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI